Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...

Researchers at the U.S. National Institutes of Health (NIH) have developed eye drops that could slow vision loss in ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

For many fellows, their time in Washington is an enlightening experience that informs the rest of their career. For some, the ...

US non-profit healthcare research system Mass General Brigham has announced that a Phase I/II trial of its stem cell therapy for cornea injuries has restored the cornea in 50% of patients after ...

The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...

The CALEC trial is the first human study of a stem cell therapy to be funded by the National Eye Institute (NEI), a part of the National Institutes of Health (NIH) and was the first stem cell ...